Cimaas logo Cimaas logo
  • About
    • Mission
    • CiMaas Team
    • Supervisory Board
    • Scientific Advisory Board
    • New therapeutic concepts
    • News archive
    • Careers
    • Collaborations
  • Technology
    • Technology
    • Adoptive NK cell therapy
    • Dendritic cell vaccine
    • Publications
  • Pipeline
  • Investors
  • General public
  • Contact
  • About
    • Mission
    • CiMaas Team
    • Supervisory Board
    • Scientific Advisory Board
    • New therapeutic concepts
    • News archive
    • Careers
    • Collaborations
  • Technology
    • Technology
    • Adoptive NK cell therapy
    • Dendritic cell vaccine
    • Publications
  • Pipeline
  • Investors
  • General public
  • Contact
Careers

CAREERS

Currently we have no vacancies

 

Acquisition as a result of this vacancy is not appreciated

Latest news
  • CiMaas filed patent application on feeder cell preparation in support of its NK cell therapy program August 23, 2023
  • CiMaas has created a master cell and working cell bank of its feeder cell line to expand NK cells with maximum proliferation July 1, 2023
  • CiMaas receives a LIOF grant to optimize feeder cells preparation facilitating expansion of Natural Killer cells  April 17, 2023
  • CiMaas receives exclusive option for the use of high affinity antibody structures in immune cells, including CAR-NK and CAR-T cells March 30, 2023
  • Dean Lee joins scientific advisory board of CiMaas December 24, 2022
  • Disclaimer
  • Contact
visual design by scicomvisuals.
  • About
  • Technology
  • Pipeline
  • General public